This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2019 Dec;21(12):1791.

doi: 10.1016/j.hpb.2019.06.010. Epub 2019 Jul 15.

Neutrophil-to-lymphocyte ratio as an indicator of prognosis in patients with pancreatic cancer

Tomoyuki Kawada¹

Affiliations

PMID: 31320242
DOI: 10.1016/j.hpb.2019.06.010

Free article

Comment

Neutrophil-to-lymphocyte ratio as an indicator of prognosis in patients with pancreatic cancer

Tomoyuki Kawada. HPB (Oxford). 2019 Dec.

Free article

. 2019 Dec;21(12):1791.

doi: 10.1016/j.hpb.2019.06.010. Epub 2019 Jul 15.

Author

Tomoyuki Kawada¹

Affiliation

¹ Department of Hygiene and Public Health, Nippon Medical School, 1-1-5 Sendagi, Bunkyo-Ku, Tokyo 113-8602, Japan. Electronic address: kawada@nms.ac.jp.

PMID: 31320242
DOI: 10.1016/j.hpb.2019.06.010

No abstract available

PubMed Disclaimer

Comment on

A meta-analysis of the utility of the neutrophil-to-lymphocyte ratio in predicting survival after pancreatic cancer resection.
Mowbray NG, Griffith D, Hammoda M, Shingler G, Kambal A, Al-Sarireh B. Mowbray NG, et al. HPB (Oxford). 2018 May;20(5):379-384. doi: 10.1016/j.hpb.2017.12.009. Epub 2018 Jan 11. HPB (Oxford). 2018. PMID: 29336893

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- ClinicalKey
- Elsevier Science
Medical
- MedlinePlus Health Information